PF-06409577
CAS No. 1467057-23-3
PF-06409577 ( PF 06409577;PF06409577;PF 6409577 )
Catalog No. M11999 CAS No. 1467057-23-3
PF-06409577(PF06409577, PF 6409577)is a potent, selective AMPK β1-containing isoforms activator with TR-FRET EC50 of 7.0 and 6.8 nM for α1β1γ1 and α2β1γ1, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 34 | In Stock |
|
5MG | 55 | In Stock |
|
10MG | 96 | In Stock |
|
25MG | 200 | In Stock |
|
50MG | 362 | In Stock |
|
100MG | 538 | In Stock |
|
500MG | 1161 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF-06409577
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-06409577(PF06409577, PF 6409577)is a potent, selective AMPK β1-containing isoforms activator with TR-FRET EC50 of 7.0 and 6.8 nM for α1β1γ1 and α2β1γ1, respectively.
-
DescriptionPF-06409577(PF06409577, PF 6409577)is a potent, selective AMPK β1-containing isoforms activator with TR-FRET EC50 of 7.0 and 6.8 nM for α1β1γ1 and α2β1γ1, respectively; displays no activity for α1β2γ1/α2β2γ1/α2β2γ3 with EC50 >40 uM; elevates the phosphorylation of AMPK in the kidney, without impacting blood glucose levels, and reduces the progression of proteinuria in rat model of diabetic nephropathy. Diabetes Phase 1 Discontinued
-
SynonymsPF 06409577;PF06409577;PF 6409577
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorAMPKα1β1γ1
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number1467057-23-3
-
Formula Weight341.79
-
Molecular FormulaC19H16ClNO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 34.2 mg/mL (100 mM); Ethanol: 6.8 mg/mL (20 mM) ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(C1=CNC2=C1C=C(C3=CC=C(C4(O)CCC4)C=C3)C(Cl)=C2)O
-
Chemical Name6-Chloro-5-[4-(1- hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cameron KO, et al. J Med Chem. 2016 Sep 8;59(17):8068-81.
2. Salatto CT, et al. J Pharmacol Exp Ther. 2017 May;361(2):303-311.
2. Salatto CT, et al. J Pharmacol Exp Ther. 2017 May;361(2):303-311.
molnova catalog
related products
-
BL-AD008
BL-AD008 (BL-AD 008) is a novel small molecule, dual-target activator targeting AMPK/ZIPK.
-
Chitosan oligosaccha...
Chitosan oligosaccharide, an oligomer of β-(1→4)-linked D-glucosamine, activates AMPK and inhibits inflammatory signaling pathways.
-
Kahweol
Kahweol has anticarcinogenic, anti-angiogenic,and anti-inflammatory activities.